The opioid-cytokine connection

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 63-69

  Peterson, Phillip K ^a,b,c   Molitor, Thomas W ^a,b,c   Chao, Chun C ^a,b,c  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

AIDS; Cytokines; HIV; Morphine; Opioid receptors; Opioids

Indexed keywords

BETA FUNALTREXAMINE; CYTOKINE; DYNORPHIN; GAMMA INTERFERON; MORPHINE; NALOXONE; OPIATE; OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CENTRAL NERVOUS SYSTEM; GLIA CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MACROGLIA; MICROGLIA; MONONUCLEAR CELL; OPIATE ADDICTION; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; MORPHINE; NARCOTICS; NEUROGLIA; NEUROIMMUNOMODULATION; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 0032520728     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00222-1     Document Type: Article

References (65)

1. Ahmed M.S., Llanos Q.J., Dinarello C.A., Blatteis C.M. Interleukin-1 reduces opioid binding in guinea pig brain. Peptides. 6:1985;1149-1154.
2. Belkowski, S.M., Zhu, J., Liu-Chen, L.Y., Eisenstein, T.K., Adler, M.W., Rogers, T.J., 1995. Detection of κ-opioid receptor mRNA in immature T cells. In: Sharp, B., Eisenstein, T., Madden, J., Friedman, H. (Eds.), The Brain Immune Axis and Substance Abuse. Plenum, New York, pp. 11-16.
3. Bendtzen K. Cytokines and natural regulators of cytokines. Immunol. Lett. 43:1994;111-123.
4. Benveniste, E.N., 1995. Cytokine production. In: Ransom, B.R. (Ed.), Neuroglia. Oxford Univ. Press, New York, pp. 700-713.
5. Bussiere J.L., Adler M.W., Rogers T.J., Eisenstein T.K. Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 264:1992;591-597.
6. Cantacuzene J. Nouvelles researches sur le mode de destruction des vibrions dans l'organisme. Ann. Inst. Pasteur. 12:1898;273-300.
7. Carr D.J.J., Kim C.-H., DeCosta B., Jacobson A.E., Rice K.C., Blalock J.E. Evidence for a δ-class opioid receptor on cells of the immune system. Cell. Immunol. 116:1988;44-51.
8. Carr D.J.J., DeCosta B.R., Kim C.-H., Jacobson A.E., Guarcello V., Rice K.C., Blalock J.E. Opioid receptors on cells of the immune system: Evidence for δ- and κ-classes. J. Endocrinol. 122:1989;161-168.
9. Chao C.C., Hu S., Molitor T.W., Zhou Y., Murtaugh M.P., Tsang M., Peterson P.K. Morphine potentiates transforming growth factor-β release from human peripheral blood mononuclear cell cultures. J. Pharmacol. Exp. Ther. 262:1992;19-24.
10. Chao C.C., Molitor T.W., Close K., Hu S., Peterson P.K. Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int. J. Immunopharmacol. 15:1993;447-453.
11. Chao C.C., Gekker G., Sheng W.S., Hu S., Tsang M., Peterson P.K. Priming effect of morphine on the production of tumor necrosis factor-α by microglia: Implications in respiratory burst of activity and human immunodeficiency virus-1 expression. J. Pharmacol. Exp. Ther. 269:1994;198-203.
12. Chao C.C., Gekker G., Hu S., Sheng W.S., Portoghese P.S., Peterson P.K. Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem. Pharmacol. 50:1995;715-722.
13. Chuang L.F., Chuang T.K., Killam K.F. Jr., Qiu Q., Wang X.R., Lin J., Kung H.F., Sheng W., Chao C.C., Yu L., Chuang R.Y. Expression of kappa opioid receptors in human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 209:1995;1003-1010.
14. Chuang T.K., Killam K.F. Jr., Chuang L.F., Kung H.F., Sheng W.S., Chao C.C., Yu L., Chuang R.Y. Mu opioid receptor glial expression in immune cells. Biochem. Biophys. Res. Commun. 216:1995;926-930.
15. Dafny N., Lee J.R., Dougherty P.M. Immune response products alter CNS activity: Interferon modulates central opioid functions. J. Neurosci. Res. 19:1988;130-139.
16. Dantzer R., Satinoff E., Kelley K.W. Cyclosporine and alpha-interferon do not attenuate morphine withdrawal in rats but do impair thermoregulation. Physiol. Behav. 39:1987;593-598.
17. De Sarro G.B., Nistico G. Naloxone antagonizes behavioural and ECoG effects induced by systemic or intracerebral administration of some lymphokines. Ann. Ist. Super. Sanita. 26:1990;99-106.
18. 3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res. 686:1995;239-248.
19. Donahoe, R.M., Falek, A., 1988. Neuroimmunomodulation by opiates and other drugs of abuse: Relationship to HIV infection and AIDS. In: Bridge, T.P., Mirsky, A.F., Goodwin, F.K. (Eds.), Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. Raven Press, New York, pp. 145-158.
20. Donnerer J., Oka K., Brossi A., Rice K.C., Spector S. Presence and formation of codeine and morphine in the rat. Proc. Natl. Acad. Sci. U.S.A. 83:1986;4566-4567.
21. Dougherty P.M., Aronowski J., Samorajski T., Dafny N. Opiate antinociception is altered by immunemodification: The effect of interferon, cyclosporine, and radiation-induced immune suppression upon acute and long-term morphine activity. Brain Res. 385:1986;401-404.
22. Eisenstein, T.K., Hilburger, M.E., Lawrence, D.M.P., 1996. Immunomodulation by morphine and other opioids. In: Friedman, H., Klein, T.W., Specter, S. (Eds.), Drugs of Abuse, Immunity and Infections. CRC Press, Boca Raton, FL, pp. 103-120.
23. Eriksson P.S., Hansson E., Rönnbäck L. δ and κ opiate receptors in primary astroglial cultures form rat cerebral cortex. Neurochem. Res. 15:1990;1123-1126.
24. Fowler C.J., Fraser G.L. μ, δ, κ-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem. Int. 24:1994;401-426.
25. Goldstein A., Barrett R.W., James I.F., Lowney L.I., Weitz C.J., Knipmeyer L.L., Rapoport H. Morphine and other opiates from beef brain and adrenal. Proc. Natl. Acad. Sci. U.S.A. 82:1985;5203-5207.
26. Heijnen C.J., Kavelaars A., Ballieux R.E. β-Endorphin: Cytokine and neuropeptide. Immunol. Rev. 119:1991;41-61.
27. Hori T., Nakashima T., Take S., Kaizuka Y., Mori T., Katafuchi T. Immune cytokines and regulation of body temperature, food intake, and cellular immunity. Brain Res. Bull. 27:1991;309-313.
28. Jeanjean A.P., Moussaoui S.M., Maloteaux J.-M., Laduron P.M. Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience. 68:1995;151-157.
29. Kapas, L., Shibata, M., Kruegger, J.M., 1995. Role of cytokines in sleep, fever, and anorexia. In: Aggarwal, B.B., Puri, R.K. (Eds.), Human Cytokines: Their Role in Disease and Therapy. Blackwell, Cambridge, MA, pp. 305-314.
30. Karagouni E.E., Hadjipetrou-Kourounakis L. Interleukins counteract opioid agonists immunosuppression. Int. J. Neurosci. 54:1990;157-163.
31. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 76:1994;253-262.
32. Lau A.S. Cytokines in the pathogenesis and treatment of infectious diseases. Adv. Pediatr. Infect. Dis. 9:1994;211-236.
33. Lawrence D.M.P., El-Hamouly W., Archer S., Leary J.F., Bidlack J.M. Identification of κ opioid receptors in the immune system by indirect immunofluorescence. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1062-1066.
34. Linner K.M., Quist H.E., Sharp B.M. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J. Immunol. 154:1995;5049-5060.
35. Lolait S.J., Clements J.A., Markwick A.J., Cheng C., McNally M., Smith A.I., Funder J.W. Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta-endorphin in spleen macrophages. J. Clin. Invest. 77:1986;1776-1779.
36. Lopher A., Abood L.G., Hoss W., Lionetti F.J. Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmacol. 29:1980;1361-1365.
37. Low K.G., Allen R.G., Melner M.H. Differential regulation of proenkephalin expression in astrocytes by cytokines. Endocrinology. 131:1992;1908-1914.
38. Makman M.H. Morphine receptors in immunocytes and neurons. Adv. Neuroimmunol. 4:1994;69-82.
39. Mehler M.F., Kessler J.A. Growth factor regulation of neuronal development. Dev. Neurosci. 16:1994;180-195.
40. Peterson P.K., Sharp B., Gekker G., Brummitt C., Keane W.F. Opioid-mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells. J. Clin. Invest. 80:1987;824-831.
41. Peterson P.K., Sharp B., Gekker G., Portoghese P.S., Sannerud K., Balfour H.H. Jr. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS. 4:1990;869-873.
42. Peterson P.K., Gekker G., Chao C.C., Schut R., Molitor T.W., Balfour H.H. Jr. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures: Involvement of transforming growth factor-β J. Immunol. 146:1991;81-84.
43. Peterson, P.K., Sharp, B.M., Gekker, G., Jackson, B., Balfour Jr, H.H., 1991. Opiates, human peripheral blood mononuclear cells, and HIV. In: Friedman, H., Klein, T., Spector, S. (Eds.), Drugs of Abuse, Immunity, and Immunodeficiency. Plenum, New York, pp. 171-178.
44. Peterson, P.K., Gekker, G., Schut, R., Hu, S., Balfour Jr, H.H., Chao, C.C., 1993. Enhancement of HIV-1 replication by opiates and cocaine: The cytokine connection. In: Friedman, H., Klein, T., Spector, S. (Eds.), Drugs of Abuse, Immunity, and AIDS. Plenum, New York, pp. 181-188.
45. Peterson P.K., Molitor T.W., Chao C.C. Mechanisms of morphine-induced immunomodulation. Biochem. Pharmacol. 46:1993;343-348.
46. Peterson P.K., Gekker G., Hu S., Anderson W.R., Kravitz F., Portoghese P.S., Balfour H.H. Jr., Chao C.C. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol. 50:1994;167-175.
47. Poli, G., Fauci, A.S., 1995. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In: Aggarwal, B.B., Puri, R.K. (Eds.), Human Cytokines: Their Role in Disease and Therapy. Blackwell, Cambridge, MA, pp. 421-449.
48. Reisine T. Opiate receptors. Neuropharmacology. 34:1995;463-472.
49. Risdahl, J., Peterson, P.K., Molitor, T.W., 1996. Opiates and infection. Adv. Neuroimmunol., in press.
50. Roy, S., Loh, H.H., Barke, R.A., 1995. Morphine-induced suppression of thymocyte proliferation is mediated by inhibition of IL-2 synthesis. In: Sharp, B., Eisenstein, T., Madden, J., Friedman, H. (Eds.), The Brain Immune Axis and Substance Abuse. Plenum, New York, pp. 41-48.
51. Shinoda H., Marini A.M., Cosi C., Schwartz J.P. Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science. 245:1989;415-417.
52. Smith E.M., Harbour-McMenamin D., Blalock J.E. Lymphocyte production of endorphins and endorphin-mediated immunoregulatory activity. J. Immunol. 135:1985;779s-782s.
53. Stefano G.B., Sharrer B. Endogenous morphine and related opiates, a new class of messengers. Adv. Neuroimmunol. 4:1994;57-67.
54. Stefanou A., Fitzharris P., Knight R.A., Lightman S.L. Characteristics and kinetics of pro-opiomelanocortin mRNA expression by human leukocytes. Brain Behav. Immun. 5:1991;319-327.
55. Steine-Martin A., Hauser K.F. Opioid-dependent growth of glial cultures: Suppression of astrocyte DNA synthesis by met-enkephalin. Life Sci. 46:1990;91-98.
56. Sundhar K.S., Kamaraju L.S., Dingfelder J., McMahon J., Gollapudi S., Wilson W.H., Kong L., Hong J.S., Weiss J.M., Lee J.E. Beta-endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. J. Neuroimmunol. 61:1995;97-104.
57. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 268:1995;251-255.
58. Vilijn M.-H., Vaysse P.J.-J., Zukin R.S., Kessler J.A. Expression of pre-proenkephalin mRNA by cultured astrocytes and neurons. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6551-6555.
59. Waage, A., Sand, T., 1995. Role of cytokines in meningitis and other neurological infections. In: Aggarwal, B.B., Puri, R.K. (Eds.), Human Cytokines: Their Role in Disease and Therapy. Blackwell, Cambridge, MA, pp. 391-399.
60. Weigent D.A., Blalock J.E. Interactions between the neuroendocrine and immune systems: Common hormones and receptors. Immunol. Rev. 100:1987;79-108.
61. Westley H.J., Kleiss A.J., Kelley K.W., Wong P.K.Y., Yuen P.-H. Newcastle disease virus-infected splenocytes express the propiomelanocortin gene. J. Exp. Med. 163:1986;1589-1594.
62. Wybran J., Appelboom T., Famaey J.-P., Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123:1979;1068-1070.
63. Xin L., Blatteis C.M. Hypothalamic neuronal responses to interleukin-6 in tissue slices: Effects of indomethacin and naloxone. Brain Res. Bull. 29:1991;27-35.
64. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., Guyre P.M. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 83:1995;500-508.
65. Zurawski G., Benedik M., Kamb B.J., Abrams J.S., Zurawski S.M., Lee F.D. Activation of mouse T-helper cells induces abundant pre-proenkephalin mRNA synthesis. Science. 232:1986;772-775.